← Leaderboards
Mark R Conaway
Boston University Medical Campus
$2,411,690
Attributed
$2,546,273
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $328.7K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,546,273 · 5
By mechanism
R01$2,128,730 · 1
R03$242,250 · 2
P01$174,587 · 1
P41$706 · 1
Top collaborators
- Richard D Stevenson2 shared
- Larry C Borish1 shared
- Peter W Heymann1 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Alexander Ozonoff$7,142,228
- Astha Singhal$1,536,127
- Anita Raj$5,527,987
- John J Stegeman$4,921,924
- Niranjan Saggurti$1,728,831
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignBaseResearch PersonnelDoseMaximum Tolerated DoseOncologyCharacteristicsProbabilityToxic EffectCytotoxic AgentDose-LimitingResponseInsightUniversitiesData AnalysesVirginiaStatistical MethodsPropertyPharmaceutical PreparationsTrial DesignMalignant NeoplasmsNew AgentsClinical Trials DesignLead
Grant awards (14)
Exploring innate immune responses to rhinovirus in allergic asthma$80,750
R03 · FY2025 · AI
An evaluation of composite endpoints using data from the EXCITE trial$80,750
R03 · FY2024 · HD · contact PI
An evaluation of composite endpoints using data from the EXCITE trial$80,750
R03 · FY2023 · HD · contact PI
Biostatistics Core$56,876
P01 · FY2022 · CA · contact PI
Biostatistics Core$58,038
P01 · FY2021 · CA · contact PI
Biostatistics Core$59,673
P01 · FY2020 · CA · contact PI
Designs for phase I trials in heterogeneous groups$314,178
R01 · FY2017 · CA · contact PI
Designs for phase I trials in heterogeneous groups$314,178
R01 · FY2016 · CA · contact PI
Designs for phase I trials in heterogeneous groups$314,178
R01 · FY2015 · CA · contact PI
Designs for phase I trials in heterogeneous groups$328,678
R01 · FY2014 · CA · contact PI
Designs for phase I trials of combinations of agents$278,497
R01 · FY2012 · CA · contact PI
Designs for phase I trials of combinations of agents$282,619
R01 · FY2011 · CA · contact PI
Designs for phase I trials of combinations of agents$296,402
R01 · FY2010 · CA · contact PI
GANGLIOSIDE SOFT VACUUM DESORPTION/IONIZATION MS (VMALDI) ON THE FINNIGAN LTQ$706
P41 · FY2004 · RR